Conclusions MVP chemotherapy combined with radiotherapy can improve survival quality, prolong survival time, improve survival rate of advanced lung adenocarcinoma.
结论MVP化疗联合放疗能改善晚期肺腺癌患者生存质量，延长生存期，提高生存率。
Objective To study the effect of MVP chemotherapy combined with radiotherapy for advanced lung adenocarcinoma.
目的探讨化疗联合放疗对晚期肺腺癌预后的影响。
Objective To study the effect of MVP chemotherapy combined with radiotherapy for advanced lung adenocarcinoma.
目的探讨化疗联合放疗对晚期肺腺癌预后的影响。
应用推荐